Drug distribution as a function of binding competition. Experiments with the distribution dialysis technique

In the distribution dialysis technique each of the two dialysis chambers contains a binding system, and a drug is allowed to distribute between them. This technique was tested by using various intracellular and extracellular binder preparations over wide concentration ranges, and model drugs selected for their known binding properties. The drugs were then tested at therapeutic concentrations in standardized systems of liver homogenate (0·5 g ml−1) and whole blood (0·02 ml ml 1) The resulting intracellular/extracellular concentration ratios were characteristic for the binding properties of the various drugs. Thus, for imipramine, a drug with strong tissue and weaker plasma binding properties, the concentration ratios were 25 for the system homogenate/buffer, 0·8 for buffer/blood, and 15 for the competitive system homogenate/blood. In experiments with homogenates from various tissues (liver, lung, kidney, intestine, brain) and blood in the standard system, the following approximate ratios were obtained: 1 for antipyrine, 2 for phenylbutazone, 14 for imipramine (but only 8 with muscle, skin and adipose tissue). These results reflect both the individual binding to intracellular and extracellular components and the tissue/blood concentration ratios in vivo. It is suggested that distribution dialysis is an in vitro method for characterizing the distribution of drugs. It is also concluded that drug distribution is largely determined by a binding competition between tissue and blood sites.

[1]  G. Wilkinson Pharmacokinetics of drug disposition: hemodynamic considerations. , 1975, Annual review of pharmacology.

[2]  M. H. Bickel,et al.  Verbessertes Gerät zur Gleichgewichts-Dialyse , 1970 .

[3]  Yoshimura Hidetoshi,et al.  Metabolism of drugs. LIX. A new metabolite of antipyrine. , 1968 .

[4]  E. Kallee,et al.  Trichloressigsäure-Aceton-Extraktion von Albuminen aus Seren und Antigen-Antikörper-Präzipitaten , 1957 .

[5]  C. D. Francesco,et al.  Membrane lipids as intracellular binders of chlorpromazine and related drugs. , 1977, Chemico-biological interactions.

[6]  R. Minchin,et al.  Chlorphentermine binding in rat lung subcellular fractions and its displacement by desmethylimipramine. , 1979, Biochemical pharmacology.

[7]  M. Bickel Binding of chlorpromazine and imipramine to red cells, albumin, lipoproteins and other blood components , 1975, The Journal of pharmacy and pharmacology.

[8]  R. Stegmann,et al.  Dominant role for tissue binding in the first-pass extraction of imipramine by the perfused rat liver. , 1977, Xenobiotica; the fate of foreign compounds in biological systems.

[9]  P. Nuhn,et al.  Calorimetric, 13C NMR, and 31P NMR studies on the interaction of some phenothiazine derivatives with dipalmitoyl phosphatidylcholine model membranes. , 1978, Biochimica et biophysica acta.

[10]  R. Schwendener,et al.  The binding of chlorpromazine to bilayer liposomes. Evaluation of stoichiometric constants from equilibrium and steady state studies. , 1978, Biochemical pharmacology.

[11]  A. Lee Local anesthesia: the interaction between phospholipids and chlorpromazine, propranolol, and practolol. , 1977, Molecular pharmacology.

[12]  E. Kallee,et al.  Bindungsfähigkeit zytoplasmatischer Proteine. I. Farbstoffbindung , 1958 .

[13]  K. Bischoff,et al.  Generalized solution to linear, to-compartment, open model for drug distribution. , 1970, Journal of theoretical biology.

[14]  J. Elferink Fluorescence studies of membrane interactions of chlorpromazine and chlorimipramine. , 1977, Biochemical pharmacology.

[15]  F. Bischoff,et al.  Orientation of circulating human estrogens by albumin. , 1957, The American journal of physiology.

[16]  P. McNamara,et al.  Effect of plasma protein and tissue binding on the biologic half‐life of drugs , 1978, Clinical pharmacology and therapy.

[17]  M. Bickel,et al.  Interactions of chlorpromazine and imipramine with artificial membranes investigated by equilibrium dialysis, dual-wavelength photometry, and fluorimetry. , 1979, Biochemical pharmacology.

[18]  M. Bickel,et al.  Binding of basic and acidic drugs to rat tissue subcellular fractions. , 1974, Chemico-biological interactions.

[19]  B. Brodie,et al.  The physiological disposition of phenylbutazone (butazolidin) in man and a method for its estimation in biological material. , 1953, The Journal of pharmacology and experimental therapeutics.

[20]  W J Jusko,et al.  Plasma and tissue protein binding of drugs in pharmacokinetics. , 1976, Drug metabolism reviews.